Filters:
Investigator: Christin Glorioso1 Projects | 1 Researchers | $249,817 Invested
2023
NeuroAge Therapeutics
Christin Glorioso, MD, PhD
A multi-omics brain aging test for tracking cognitive sharpness and risk of dementia
Our portfolio includes grants and mission-related investments supporting Alzheimer’s drugs in development, biomarkers, prevention programs, and other projects designed to build the capacity of the field. You can explore the programs we have supported using the filter and “Search Database” options in the sidebar.
Christin Glorioso, MD, PhD
A multi-omics brain aging test for tracking cognitive sharpness and risk of dementia